🔎 Trials Near Me

Dachaigh › Lymphoma Cealla-B › Michigan

Sgrùdaidhean clionaigeach Lymphoma Cealla-B ann an Michigan

Tha 7 sgrùdaidhean airson Lymphoma Cealla-B a’ lorg phàirtichean aig làraichean ann an Michigan.

Bailtean ann an Michigan

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  • University of Michigan, Ann Arbor
  • The Cancer and Hematology Centers, Grand Rapids
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • University of Michigan Comprehensive Cancer Center, Ann Arbor
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07101328

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

  • Clinical Trial Site, Detroit
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06393738

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Corewell Health, Grand Rapids
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535

Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma

  • University of Michigan Rogel Cancer Center, Ann Arbor
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT07532525

DALY II USA/ MB-CART2019.1 for DLBCL

  • University of Michigan, Ann Arbor
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT04792489

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • C.S. Mott Children's Hospital, Ann Arbor
A’ fastadhÌre 1
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Dùbh 2024 · NCT05476770

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.